JPRN-UMIN000023466
Completed
Phase 2
Study of the glucose metabolism-improving effect of the 12-week intake of beverages containing lactic acid bacteria - Study of the glucose metabolism-improving effect of the 12-week intake of beverages containing lactic acid bacteria
HUMA R&D CORP0 sites130 target enrollmentAugust 3, 2016
ConditionsHyperglycemia
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Hyperglycemia
- Sponsor
- HUMA R&D CORP
- Enrollment
- 130
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\. Subjects in the drug therapy or in the hospital care 2\. Sever systemic diseases affecting the results of this study 3\. Subjects with an immunodeficiency 4\. Subjects with a previous history or merger of malignant tumors 5\. Subjects in pregnancy or in nursing 6\. Subjects with a habit of intake more than twice in a week of fermented milk or lactic fermenting beverage in three months before screening test 7\. Constant use of oral medication or supplements affecting glucese or lipid matabolism in three months before screening test 8\. Subjects with food allergy or medicine allergy 9\. Subjects who drink a lot of alcohol 10\. Subjects who participated in other clinical trials within one month before the agreement of participants in this study 11\. Subjects who are judged as unsuitable for the study by the investigator for other reasons
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 2
Study of the glucose metabolism-improving effect of the 12-week intake of food containing lactic acid bacteria: A randomized, double-blind, placebo-controlled, parallel-group studyHyperglycemiaJPRN-UMIN000032837KSO Corporation130
Completed
Not Applicable
Study of the glucose metabolism-improving effect of the 12-week intake of test food containing lactic acid bacteria: A randomized, double-blind, placebo-controlled, parallel-group studyHyperglycemiaJPRN-UMIN000047804KSO Corporation148
Completed
Not Applicable
The impact of the improvement of glycometabolism in patients with type 2 diabetes on sleep disturbance including sleep disordered breathing following an admission to control their glucose metabolism.type 2 diabetes with sleep disturbance including sleep disordered breathingJPRN-UMIN000045728ihon University of Medicine80
Completed
Not Applicable
Examination of the glucose metabolism improvement effects by the combination of DPP-4 inhibitor and SGLT2 inhibitorType 2 diabetes mellitusJPRN-UMIN000030043niversity of Miyazaki , fuculty of medicine, Endocrinology, Metabolism and Diabetes Mellitus, Department of Internal Medicine15
Completed
Phase 4
Study for the effect of blood glucose and metabolic risk factors by switching Sulfonylurea to SGLT2 inhibitor in patients with type 2 diabetes. -prospective observational studyType 2 diabetes mellitusJPRN-UMIN000016347Hokkaido University Hospital200